Venaxis Inc. (Nasdaq: APPY) reported positive results from a study of its APPY1 Test to identify patients who are at low risk for appendicitis sending the stock price soaring 61 cents to $3.32.
Positive Results For Venaxis
March 13, 2014 at 04:47 AM EDT
